← Human Trials & Peer-Reviewed Studies
The effect of menaquinone-7 supplementation on vascular calcification in patients with diabetes: a randomized, double-blind, placebo-controlled trial
Plain-language guide to PMID 31387121 (2019): double-blind randomized controlled trial study of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 31387121
- Journal
- The American journal of clinical nutrition
- Year
- 2019
- Study type
- Randomized Controlled Trial
- Authors
- Zwakenberg SR et al. (15 authors)
- DOI
- 10.1093/ajcn/nqz147
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.
Dephosphorylated-uncarboxylated matrix Gla protein (dp-ucMGP) concentrations were measured to assess compliance.
Why It Was Studied
Vitamin K occurs in the diet as phylloquinone and menaquinones.
However, the effect of vitamin K on vascular calcification is unknown.
Who Took Part
The age groups tagged for this paper are middle-aged adults and older adults, both men and women.
Linear regression analyses were performed with either TBR or CT calcification at follow-up as the dependent variable, and treatment and baseline TBR or CT calcification as independent variables.
How the Study Was Run
In design terms this was a randomized, double-blind and placebo-controlled study.
The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.
Blinding on both sides kept the participants and researchers unaware of who received Vitamin D, K2, Magnesium and Zinc.
A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.
Calcification mass on conventional computed tomography (CT) scan was measured as secondary outcome.
What Was Measured
PubMed files the paper under topics including Diabetes Mellitus, Type 2, Dietary Supplements, Vascular Calcification and Vitamin K 2.
The authors tagged it with the keywords cardiovascular disease and menaquinone-7.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc.
Its findings take up roughly 8 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2019 (The American journal of clinical nutrition), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.